Eric Pauwels, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 5,890 shares at $50.12 ($295K) on 2025-02-20, disclosed to the SEC on 2025-02-21.
Scheduled sale ($295k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 1,378 | $69K | 23.4% |
| 2 | $50.10 | 1,378 | $69K | 23.4% |
| 3 | $50.12 | 1,567 | $79K | 26.6% |
| 4 | $50.12 | 1,567 | $79K | 26.6% |
| Total | $50.11 avg | 5,890 | $295K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |